Amy E. Armstrong - Concepedia

Author

Amy E. Armstrong

Lurie Children's Hospital ORCID

Also Known As

A E Armstrong, A. Armstrong, Amy Armstrong, Amy E Armstrong, Amy E. Armstrong, Armstrong, Amy E., He, Yongzheng

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Lurie Children's Hospital Northwestern University Indiana University – Purdue University Indianapolis National Cancer Institute Washington University in St. Louis

About

Amy E. Armstrong is an author at Lurie Children's Hospital specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	10	1K
2	Engineering	1	1	123
3	Health Sciences	1	1	362
4	Cell Biology	1	1	90
5	Epidemiology	1	1	123

Amy E. Armstrong

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
A Children's Oncology Group and TARGET initiative exploring the genetic landscape of Wilms tumor Samantha Gadd, Vicki Huff, Amy L. Walz, Nature Genetics Genetic LandscapeOncology GroupTumor HeterogeneityWilms TumorGenetics	2017	362
Noninvasive Diagnosis of Infection Using Plasma Next-Generation Sequencing: A Single-Center Experience Jenna Rossoff, Sonali Chaudhury, Maulin Soneji, Open Forum Infectious Diseases EngineeringAvailable Diagnostic TestingDiagnosisNoninvasive DiagnosisPediatric Epidemiology	2019	123
Entrectinib in children and young adults with solid or primary CNS tumors harboring <i>NTRK</i>, <i>ROS1</i>, or <i>ALK</i> aberrations (STARTRK-NG) Ami V. Desai, Giles Robinson, Karen Gauvain, Neuro-Oncology	2022	121
Cell‐free DNA next‐generation sequencing successfully detects infectious pathogens in pediatric oncology and hematopoietic stem cell transplant patients at risk for invasive fungal disease Amy E. Armstrong, Jenna Rossoff, Desiree Hollemon, Pediatric Blood & Cancer	2019	103
Cdkn2a (Arf) loss drives NF1-associated atypical neurofibroma and malignant transformation Steven D. Rhodes, Yongzheng He, Abbi E. Smith, Human Molecular Genetics Neuro-oncologyPlexiform NeurofibromaGliomaMedicineMalignant Transformation	2019	90
Cabozantinib for neurofibromatosis type 1–related plexiform neurofibromas: a phase 2 trial Michael J. Fisher, Chie‐Schin Shih, Steven D. Rhodes, Nature Medicine Neuro-oncologyFibrosisPlexiform NeurofibromasNeurofibromatosis Type 1–RelatedPathology	2021	85
Anatomic Guidelines for Harvesting a Quadriceps Free Tendon Autograft for Anterior Cruciate Ligament Reconstruction Julienne Lippe, Amy E. Armstrong, John P. Fulkerson Arthroscopy The Journal of Arthroscopic and Related Surgery Anatomic GuidelinesReconstructive SurgerySurgeryArthroscopic TechniqueMusculoskeletal Surgery	2012	82
Phase II study of single-agent cabozantinib in patients with recurrent clear cell ovarian, primary peritoneal or fallopian tube cancer (NRG-GY001) Panagiotis A. Konstantinopoulos, William E. Brady, John Farley, Gynecologic Oncology Gastrointestinal OncologyMedicineMetronomic TherapyGynecologyPhase Ii Study	2018	63
Peptides from cytomegalovirus UL130 and UL131 proteins induce high titer antibodies that block viral entry into mucosal epithelial cells Frances M. Saccoccio, Anne Sauer, Xiaohong Cui, Vaccine Viral PathogenesisImmunologyPathologyVirologyImmunologic Mechanism	2011	59
A unique subset of low-risk Wilms tumors is characterized by loss of function of TRIM28 (KAP1), a gene critical in early renal development: A Children’s Oncology Group study Amy E. Armstrong, Samantha Gadd, Vicki Huff, PLoS ONE Epigenetic ChangeGeneticsRenal PathologyDna MethylationPathology	2018	41

Page 1